Post by Goldman Sachs
5,955,908 followers
Is healthcare the next overlooked beneficiary of AI and reshoring? Ben Silver, Co-CIO of Maverick Capital, joined Exchanges: Great Investors to explain why the life science tools space could be poised for a CapEx boom and revision cycle as drug manufacturing reshores to the US over the next three to six months. Listen to the full episode: https://click.gs.com/tvcz
Video Content